Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsAdnexal Diseases, Biliary Tract Neoplasms, Carcinoma, Ovarian Epithelial, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, biliary tract disorder, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cholangiocarcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, esophageal adenocarcinoma, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, transitional cell carcinoma, uterine disorderRecruitingPhase 12026-05-20NCT07334119

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
CREATE Medicines3
Myeloid Therapeutics4

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cabrini HealthMelbourneAustralia3
Calvary Mater NewcastleWaratahAustralia49
Cancer Research SA Pty LtdAdelaideAustralia2
Icon Cancer Centre South BrisbaneSouth BrisbaneAustralia9
Linear Clinical ResearchNedlandsAustralia23
Scientia Clinical Research LtdRandwickAustralia11
The Kinghorn Cancer CentreDarlinghurstAustralia2